These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15310993

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 3-D computer visualization and interactive prostate biopsy simulation leads to an improved systematic technique for the detection of prostate cancer: clinical correlation.
    Bauer JJ, Zeng J, Zhang W, McLeod DG, Sesterhenn IA, Connelly RR, Mun SK, Moul JW.
    Stud Health Technol Inform; 2000; 70():20-5. PubMed ID: 10977540
    [Abstract] [Full Text] [Related]

  • 23. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.
    Urol Int; 2009; 82(3):280-5. PubMed ID: 19440014
    [Abstract] [Full Text] [Related]

  • 24. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 01; 88(1):16-8. PubMed ID: 18346372
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter study.
    Sözen S, Eskicorapci S, Küpeli B, Irkilata L, Altinel M, Ozer G, Uygur C, Alkibay T, Ozen H.
    Eur Urol; 2005 Mar 01; 47(3):302-7. PubMed ID: 15716190
    [Abstract] [Full Text] [Related]

  • 28. Utility of percent free prostate-specific antigen in repeat prostate biopsy.
    Lee BH, Hernandez AV, Zaytoun O, Berglund RK, Gong MC, Jones JS.
    Urology; 2011 Aug 01; 78(2):386-91. PubMed ID: 21683989
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
    Raaijmakers R, de Vries SH, Blijenberg BG, Wildhagen MF, Postma R, Bangma CH, Darte C, Schröder FH.
    Eur Urol; 2007 Nov 01; 52(5):1358-64. PubMed ID: 17499425
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Detection rate of histologically insignificant prostate cancer with systematic sextant biopsies and fine needle aspiration cytology.
    Hautmann SH, Conrad S, Henke RP, Erbersdobler A, Simon J, Straub M, Graefen M, Hautmann RE, Huland H.
    J Urol; 2000 Jun 01; 163(6):1734-8. PubMed ID: 10799171
    [Abstract] [Full Text] [Related]

  • 33. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS, Swords K, Schultz H, Carson CC, Wallen EM.
    J Urol; 2009 Feb 01; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
    Mariappan P, Chong WL, Sundram M, Mohamed SR.
    BJU Int; 2004 Aug 01; 94(3):307-10. PubMed ID: 15291857
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
    Gann PH, Ma J, Catalona WJ, Stampfer MJ.
    J Urol; 2002 Jun 01; 167(6):2427-34. PubMed ID: 11992051
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR, Zippe CD, Abouassaly R, Schoenfield L, Magi-Galluzzi C, Jones JS.
    J Urol; 2008 May 01; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.